Platform

The TetraKit platform revolutionizes radiolabeling with its proprietary click chemistry, facilitating rapid and mild labeling conditions without requiring purification of the final product. This versatile approach is applicable across various molecules such as small molecules, peptides, antibodies, or nanoparticles, making it ideal for theranostic applications. Its kit-labeling strategy ensures easy implementation in radiopharmacies, enabling efficient production of radiopharmaceuticals.

Platform

Pipeline

TetraKit Technologies is advancing a pipeline of innovative radiopharmaceuticals based on our proprietary TetraKit platform, designed to simplify and accelerate the radiolabeling of therapeutic and diagnostic agents. Our focus is on targeted alpha therapies for oncology indications with high unmet medical need. All pipeline programs are enabled by our versatile radiolabeling chemistry, supporting a broad range of radiohalogens including astatine-211, fluorine-18 and iodine-123/131.

Pipeline